![James Stonecypher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Stonecypher
Corporate Officer/Principal bei
TELIX PHARMACEUTICALS LIMITED
Profil
James Stonecypher currently works at Object Pharma, Inc., as Chief Executive Officer and Telix Pharmaceuticals Ltd., as Chief Development Officer from 2023.
Mr. Stonecypher received his undergraduate degree from the University of Southern California and graduate degree from The Johns Hopkins University.
Aktive Positionen von James Stonecypher
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01.12.2022 |
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Vorstandsvorsitzender | - |
Ausbildung von James Stonecypher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Health Technology |
